Skip to search formSkip to main contentSkip to account menu

Doxil

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Liposomes are the first nano drug delivery systems that have been successfully translated into real-time clinical applications… 
Review
2012
Review
2012
  • Y. Barenholz
  • Journal of controlled release : official journal…
  • 2012
  • Corpus ID: 20734524
Highly Cited
2004
Highly Cited
2004
BACKGROUND This study was designed to demonstrate that efficacy [progression-free survival (PFS)] of CAELYX [pegylated liposomal… 
Highly Cited
2003
Highly Cited
2003
BACKGROUND Pegylated liposomal doxorubicin (Doxil) has been reported to cause immediate hypersensitivity reactions (HSRs) that… 
Review
2003
Review
2003
Pegylated liposomal doxorubicin (doxorubicin HCl liposome injection; Doxil® or Caelyx®) is a liposomal formulation of doxorubicin… 
Review
2000
Review
2000
BACKGROUND The indications for pegylated liposomal doxorubicin (doxil) are expanding. We, therefore, wished to assess the safety… 
Highly Cited
2000
Highly Cited
2000
Doxil (ALZA Corp., Mountain View, CA) is a formulation of doxorubicin in polyethylene‐glycol coated liposomes with a prolonged…